Pulse Biosciences Cash Jumps in Q2
Pulse Biosciences ( NASDAQ:PLSE ) , a medical device innovator focused on nanosecond pulsed field ablation ( nsPFA ) for treating various conditions, released its second-quarter 2025 results on August 12, 2025. The company reported another pre-commercial quarter, with no revenue.
Corvus Pharmaceuticals Appoints Richard A. van den Broek to Board of Directors - Corvus Pharma ( NASDAQ:CRVS )
SOUTH SAN FRANCISCO, Calif., April 09, 2025 ( GLOBE NEWSWIRE ) -- Corvus Pharmaceuticals, Inc. CRVS, a clinical-stage biopharmaceutical company, announced today that Richard van den Broek, managing partner at HSMR Advisors, has been appointed to the Company's board of directors.
Loar Holdings Posts Upbeat Results, Joins Nvidia, Clean Energy Fuels, Penumbra And Other Big Stocks Moving Higher On Tuesday - Loar Holdings ( NYSE:LOAR )
U.S. stocks were higher, with the Dow Jones index gaining around 200 points on Tuesday. Shares of Loar Holdings Inc. LOAR rose sharply during Tuesday's session after the company reported better-than-expected second-quarter GAAP EPS and sales.
Pulse Biosciences ( NASDAQ:PLSE ) Stock Rating Upgraded by StockNews.com
Pulse Biosciences ( NASDAQ:PLSE - Get Free Report ) was upgraded by stock analysts at StockNews.com to a "sell" rating in a research note issued on Thursday. NASDAQ:PLSE opened at $14.86 on Thursday. Pulse Biosciences has a twelve month low of $3.78 and a twelve month high of $17.05.
Pulse Biosciences ( NASDAQ:PLSE ) Raised to "Sell" at StockNews.com
Pulse Biosciences ( NASDAQ:PLSE - Get Free Report ) was upgraded by equities research analysts at StockNews.com to a "sell" rating in a research report issued on Thursday. PLSE opened at $14.86 on Thursday. The firm has a market capitalization of $820.57 million, a P/E ratio of -18.35 and a ...
Corning Increases Sales Forecast, Joins Morphic Holding, Lucid Group And Other Big Stocks Moving Higher On Monday - Corning ( NYSE:GLW )
U.S. stocks were higher, with the Dow Jones index surging around 200 points on Monday. Shares of Corning Incorporated GLW rose sharply during Monday's session after the company increased its second-quarter core sales guidance.
Pulse Biosciences ( NASDAQ:PLSE ) Upgraded by StockNews.com to "Sell"
StockNews.com upgraded shares of Pulse Biosciences ( NASDAQ:PLSE - Free Report ) to a sell rating in a research report report published on Thursday morning. NASDAQ:PLSE opened at $11.01 on Thursday. Pulse Biosciences has a 12 month low of $3.78 and a 12 month high of $14.96.
Oxford Industries, PVH And 3 Stocks To Watch Heading Into Monday - PVH ( NYSE:PVH ) , Oxford Industries ( NYSE:OXM )
With U.S. stock futures trading higher this morning on Monday, some of the stocks that may grab investor focus today are as follows: Wall Street expects PVH Corp. PVH to report quarterly earnings at $3.52 per share on revenue of $2.42 billion after the closing bell, according to data from ...
Pulse Biosciences Gets FDA 510 ( k ) Clearance For CellFX NsPFA Percutaneous Electrode System
Pulse Biosciences Gets FDA 510(k) Clearance For CellFX NsPFA Percutaneous Electrode System ...
Rivian Automotive Reports Weak Delivery Figures, Joins JOYY, MiMedx Group And Other Big Stocks Moving Lower On Tuesday - Amprius Technologies ( NYSE:AMPX ) , ARM Holdings ( NASDAQ:ARM )
U.S. stocks traded mostly lower, with the Nasdaq Composite falling around 200 points on Tuesday. Shares of Rivian Automotive, Inc. RIVN fell sharply during Tuesday's session after the company reported delivery and production figures for 2023.
Top 5 NASDAQ Medical Device Stocks of 2023
The growing prevalence of chronic diseases like cancer and diabetes is driving increasing innovation in medical device technology. In 2023 alone,40 new devices were approved by the US Food and Drug Administration ( FDA ) .
$10M Bet On This Healthcare Stock? Check Out These 4 Stocks Insiders Are Buying - Planet Fitness ( NYSE:PLNT ) , EyePoint Pharmaceuticals ( NASDAQ:EYPT )
Although U.S. stocks closed higher on Tuesday, there were a few notable insider trades. When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock.
Insiders Buying Dave And 2 Other Stocks - Dave ( NASDAQ:DAVE ) , EyePoint Pharmaceuticals ( NASDAQ:EYPT )
Although U.S. stocks closed lower on Wednesday, there were a few notable insider trades. When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock.
Insiders Buying Westrock Coffee And 3 Other Stocks - Howard Hughes Holdings ( NYSE:HHH ) , Empire Petroleum ( AMEX:EP )
When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading ...
Agilent Posts Upbeat Results, Joins Burlington Stores, Hibbett And Other Big Stocks Moving Higher On Tuesday - Agilent Technologies ( NYSE:A ) , Artivion ( NYSE:AORT )
U.S. stocks traded lower, with the Dow Jones falling around 90 points on Tuesday. Shares of Agilent Technologies, Inc. A jumped during Tuesday's session after the company reported better-than-expected fourth-quarter financial results.
Pulse Biosciences ( NASDAQ:PLSE ) Rating Increased to Sell at StockNews.com
Pulse Biosciences ( NASDAQ:PLSE ) Rating Increased to Sell at ... Defense World ...
Innovations in Cardiac Ablation Technology Take Center Stage: Key Companies Leading the PFA Revolution
DUBLIN, Oct. 19, 2023 /PRNewswire/ -- The "Pulsed Field Ablation Market by Therapeutic Area, Product Components, Application Areas, Source of Ablation, and Key Geographical Regions: Market Share of Key Companies, Industry Trends and Global Forecasts, 2023-2035" report has been added to ...
Director at Pulse Biosciences Exercises Options Worth $13K - Pulse Biosciences ( NASDAQ:PLSE )
ROBERT DUGGAN, Director at Pulse Biosciences PLSE, reported a large exercise of company stock options on July 27, according to a new SEC filing. What Happened: A Form 4 filing from the U.S.
Pulse Biosciences Recent Insider Activity - Pulse Biosciences ( NASDAQ:PLSE )
Robert W Duggan, Board Member at Pulse Biosciences PLSE, reported a large insider buy on May 10, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Wednesday showed that Duggan purchased 10,022,937 shares of Pulse Biosciences.
Over $65M Bet On This Healthcare Stock? Check Out These 3 Stocks Insiders Are Buying - Herbalife ( NYSE:HLF ) , Pulse Biosciences ( NASDAQ:PLSE )
Although US stocks closed mixed on Wednesday, there were a few notable insider trades. When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock.
Pulse Biosciences ( NASDAQ:PLSE ) Raised to "Sell" at StockNews.com
Pulse Biosciences ( NASDAQ:PLSE ) Raised to "Sell" at StockNews ... Defense World ...
Latest Executive Changes In Marijuana Industry, New Appointments & Resignations - Anebulo Pharmaceuticals ( NASDAQ:ANEB ) , Akanda ( NASDAQ:AKAN )
As the Benzinga Cannabis Capital Conference returns to Miami ( April 11-12 ) , gathering top CEOs, investors and leaders in the marijuana industry, let's scroll through the latest leadership changes in the space. Charlotte's Web Holdings, Inc.
Lifshitz Law PLLC Announces Investigations of Natera, Inc. ( NASDAQ: NTRA ) , Butterfly Network, Inc. ( NYSE: BFLY ) , Pulse Biosciences, Inc. ( NASDAQ: PLSE ) , and SunPower Corporation ( NASDAQ: SPWR ) - Natera ( NASDAQ:NTRA ) , Butterfly Network ( NYSE:BFLY )
NEW YORK, Nov. 19, 2022 ( GLOBE NEWSWIRE ) -- Lifshitz Law PLLC announces that a class action complaint was filed on behalf of shareholders of Natera alleging that Defendants misrepresented and/or failed to disclose that: ( i ) the Company's Panorama Non-Invasive Prenatal Test was not ...
Pulse Biosciences ( NASDAQ:PLSE ) Coverage Initiated at StockNews.com
Research analysts at StockNews.com began coverage on shares of Pulse Biosciences ( NASDAQ:PLSE - Get Rating ) in a report released on Wednesday. The firm set a "sell" rating on the stock. Separately, Maxim Group downgraded Pulse Biosciences from a "buy" rating to a "hold" rating in a research ...
StockNews.com Begins Coverage on Pulse Biosciences ( NASDAQ:PLSE )
Stock analysts at StockNews.com initiated coverage on shares of Pulse Biosciences ( NASDAQ:PLSE - Get Rating ) in a research note issued on Tuesday. The brokerage set a "sell" rating on the stock. Separately, Maxim Group downgraded Pulse Biosciences from a "buy" rating to a "hold" rating in a ...
Pulse Biosciences ( NASDAQ:PLSE ) Earns Sell Rating from Analysts at StockNews.com
Stock analysts at StockNews.com started coverage on shares of Pulse Biosciences ( NASDAQ:PLSE - Get Rating ) in a research note issued to investors on Monday. The firm set a "sell" rating on the stock.
Hot Penny Stocks To Watch As The Stock Market Crash Continues
The stock market is down again today. Why? Concerns stemming from last week's Fed meeting and plenty of Fed speak this week have contributed to the latest stock market rout. But that hasn't been the same when it comes to penny stocks.
Pulse Biosciences Lead Therapeutic System Scores FDA Approval For Sebaceous Hyperplasia - Pulse Biosciences ( NASDAQ:PLSE )
The FDA has granted 510 ( k ) clearance to Pulse Biosciences Inc's PLSE CellFX System, expanding the indication for use to include the treatment of sebaceous hyperplasia in patients with Fitzpatrick skin types I-III. Sebaceous hyperplasia is a very common non-contagious skin condition.
Pulse Biosciences ( NASDAQ:PLSE ) Receives New Coverage from Analysts at StockNews.com
StockNews.com began coverage on shares of Pulse Biosciences ( NASDAQ:PLSE - Get Rating ) in a research note issued to investors on Sunday. The brokerage issued a sell rating on the stock. Separately, Maxim Group lowered Pulse Biosciences from a buy rating to a hold rating in a research report ...
Pulse Biosciences ( NASDAQ:PLSE ) Coverage Initiated by Analysts at StockNews.com
Research analysts at StockNews.com initiated coverage on shares of Pulse Biosciences ( NASDAQ:PLSE - Get Rating ) in a research report issued to clients and investors on Sunday. The brokerage set a "sell" rating on the stock.
Pulse Biosciences Shifts Core Technology Focus, Reduces Dermatologic Footprint - Pulse Biosciences ( NASDAQ:PLSE )
Bioelectric medicine company Pulse Biosciences Inc PLSE announced a shift in focus to advance core NPS technology in the cardiac and oncology sectors. The company's proprietary Nano-Pulse Stimulation ( NPS ) technology delivers nanosecond pulses of electrical energy to non-thermally clear cells ...
StockNews.com Begins Coverage on Pulse Biosciences ( NASDAQ:PLSE )
StockNews.com started coverage on shares of Pulse Biosciences ( NASDAQ:PLSE - Get Rating ) in a research report released on Saturday. The firm issued a sell rating on the stock. Shares of NASDAQ PLSE opened at $1.43 on Friday.
Pulse Biosciences, Inc ( PLSE ) Reports Q2 Loss, Lags Revenue Estimates
Pulse Biosciences, Inc (PLSE) delivered earnings and revenue surprises of 0% and 52.17%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Pulse Biosciences ( NASDAQ:PLSE ) Upgraded by StockNews.com to Sell
StockNews.com upgraded shares of Pulse Biosciences ( NASDAQ:PLSE - Get Rating ) to a sell rating in a report released on Thursday. Several other research analysts have also commented on PLSE. Stephens lowered Pulse Biosciences from an overweight rating to an equal weight rating in a research ...
Recap Of Thursday's Biotech Catalysts - End Of the Day Summary
The European Commission ( EC ) has approved AstraZeneca AZN and Merck's MRK LYNPARZA as monotherapy or in combination with endocrine therapy for the adjuvant treatment of adult patients with germline BRCA1/2 mutations ( gBRCAm ) . This regulatory approval was supported by the results from the ...
StockNews.com Upgrades Pulse Biosciences ( NASDAQ:PLSE ) to Sell
Pulse Biosciences ( NASDAQ:PLSE - Get Rating ) was upgraded by investment analysts at StockNews.com to a "sell" rating in a report issued on Thursday.
Summit Therapeutics Appoints Dr. Maky Zanganeh as Co-CEO & President
Menlo Park, California, July 26, 2022 ( GLOBE NEWSWIRE ) -- Summit Therapeutics Inc. SMMT announces that Dr. Maky Zanganeh, DDS, MBA, has been appointed as Co-Chief Executive Officer & President, effective immediately.
Pulse Biosciences ( NASDAQ:PLSE ) Raised to Sell at StockNews.com
StockNews.com upgraded shares of Pulse Biosciences ( NASDAQ:PLSE - Get Rating ) to a sell rating in a report published on Friday morning. PLSE has been the topic of a number of other research reports. Maxim Group initiated coverage on Pulse Biosciences in a report on Friday, April 1st.
Pulse Biosciences ( NASDAQ:PLSE ) Rating Increased to Sell at StockNews.com
Pulse Biosciences ( NASDAQ:PLSE - Get Rating ) was upgraded by analysts at StockNews.com to a "sell" rating in a report released on Friday. A number of other equities analysts have also weighed in on the stock. Maxim Group initiated coverage on shares of Pulse Biosciences in a research report ...
Pulse Biosciences ( NASDAQ:PLSE ) Upgraded by StockNews.com to Sell
Pulse Biosciences ( NASDAQ:PLSE - Get Rating ) was upgraded by stock analysts at StockNews.com to a "sell" rating in a report issued on Friday. PLSE has been the subject of a number of other reports.
Pulse Biosciences ( NASDAQ:PLSE ) Stock Rating Upgraded by StockNews.com
Pulse Biosciences ( NASDAQ:PLSE - Get Rating ) was upgraded by equities researchers at StockNews.com to a "sell" rating in a note issued to investors on Wednesday.
Pulse Biosciences ( NASDAQ:PLSE ) Stock Rating Upgraded by StockNews.com
Pulse Biosciences ( NASDAQ:PLSE - Get Rating ) was upgraded by equities researchers at StockNews.com to a "sell" rating in a report released on Wednesday. Several other equities analysts also recently commented on the stock.
73 Biggest Movers From Yesterday
Gainers AgriFORCE Growing Systems Ltd. ( NASDAQ: AGRI ) shares jumped 65.9% to close at $2.77 on Monday after gaining around 10% on Friday. NewAge, Inc. ( NASDAQ: NBEV ) gained 65.8% to settle at $0.4245. Data Storage Corporation ( NASDAQ: DTST ) shares climbed 50% to close at $3.45 on Monday
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers Harpoon Therapeutics ( NASDAQ:HARP ) shares increased by 38.0% to $2.76 during Monday's regular session. As of 13:30 EST, this security is trading at a volume of 1.1 million shares, making up 325.1% of its average full-day volume over the last 100 days. The market value of their outstandin
90 Biggest Movers From Yesterday
Gainers Allena Pharmaceuticals, Inc. ( NASDAQ: ALNA ) surged 70.5% to close at $0.1330 on Thursday after declining 9% on Wednesday. Allena Pharmaceuticals recently reported a $2.8 million registered direct offering. Squarespace, Inc. ( NYSE: SQSP ) jumped 48.5% to close at $21.44 after the comp
Pulse Biosciences, Inc ( PLSE ) Reports Q1 Loss, Lags Revenue Estimates
Pulse Biosciences, Inc (PLSE) delivered earnings and revenue surprises of 5.88% and 36.57%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Stocks That Hit 52-Week Lows On Wednesday
On Wednesday, 807 companies reached new 52-week lows.
Things to Consider About Today's 52-Week Lows:
Amazon.com ( NASDAQ:AMZN ) was the largest company by market cap to set a new 52-week low.
Games & Esports ( NASDAQ:GEEXW ) was the smallest company by market cap to set a new 52-week low.
View
Earnings Scheduled For May 11, 2022
Companies Reporting Before The Bell
• Great Elm Capital ( NASDAQ:GECC ) is expected to report earnings for its first quarter.
• Trevena ( NASDAQ:TRVN ) is projected to report earnings for its first quarter.
• Life Time Group Hldgs ( NYSE:LTH ) is likely to report quarterly loss at $0.41 per sh
Stocks That Hit 52-Week Lows On Thursday
During Thursday, 849 stocks hit new 52-week lows.
Areas of Significance In Today's 52-Week Lows:
JPMorgan Chase ( NYSE:JPM ) was the largest company by market cap to set a new 52-week low.
Reshape Lifesciences ( NASDAQ:RSLS ) was the smallest company by market cap to set a new 52-week low.
Sio G
Stocks That Hit 52-Week Lows On Tuesday
During Tuesday, 581 stocks hit new 52-week lows.
Interesting Highlights From Today's 52-Week Lows
Meta Platforms ( NASDAQ:FB ) was the biggest company on a market cap basis to set a new 52-week low.
The smallest company by market cap to set a new 52-week low was AnPac Bio-Medical Science ( NASDAQ
